186 related articles for article (PubMed ID: 8623420)
1. Immunohistological study of islet xenograft rejection in immunosuppressed recipients.
Andereggen E; Bühler L; Fournier B; Deng S; Bubloz C; Morel P
Transplant Proc; 1996 Apr; 28(2):826-8. PubMed ID: 8623420
[No Abstract] [Full Text] [Related]
2. Comparison of concordant and discordant xenografted islets of Langerhans rejection.
Bühler L; Deng S; Andereggen E; Bubloz C; Rohner A; Morel P
Transplant Proc; 1994 Dec; 26(6):3453-4. PubMed ID: 7998218
[No Abstract] [Full Text] [Related]
3. Islets of Langerhans rejection: allo vs xenotransplantation in animals.
Bühler L; Deng S; Mage SR; Bubloz C; Rohner A; Morel P
Transplant Proc; 1994 Apr; 26(2):764-5. PubMed ID: 8171653
[No Abstract] [Full Text] [Related]
4. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
[No Abstract] [Full Text] [Related]
5. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
Wright JR; Kearns H
Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
[No Abstract] [Full Text] [Related]
6. Treatment with antibodies to leucocyte function-associated antigen-1 prolongs the survival of xenotransplanted islets of Langerhans.
Bühler L; Deng S; Grau G; Mentha G; Rohner A; Morel P
Transplant Proc; 1994 Jun; 26(3):1360-1. PubMed ID: 8029940
[No Abstract] [Full Text] [Related]
7. Effect of 15-deoxyspergualin in islet xenograft rejection.
Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
[No Abstract] [Full Text] [Related]
8. Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506.
Tze WJ; Tai J; Cheung SS; Murase N; Starzl TE
Transplant Proc; 1994 Apr; 26(2):768-9. PubMed ID: 7513470
[No Abstract] [Full Text] [Related]
9. Prolongation of islet xenograft survival with combined treatment of 15-deoxyspergualin or cyclosporine and anti-CD4 monoclonal antibody.
Lu X; Borel JF
Transplant Proc; 1995 Feb; 27(1):298-9. PubMed ID: 7879010
[No Abstract] [Full Text] [Related]
10. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
[No Abstract] [Full Text] [Related]
11. Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study.
Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Sehgal SN; Nakhleh RE; Gruessner RW
Transplant Proc; 1996 Apr; 28(2):981-3. PubMed ID: 8623487
[No Abstract] [Full Text] [Related]
12. Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.
Fukuzaki T; Gotoh M; Hasuike Y; Tanigawa T; Nagano H; Umeshita K; Kanai T; Monden M; Mori T
Transplant Proc; 1994 Apr; 26(2):779. PubMed ID: 7513472
[No Abstract] [Full Text] [Related]
13. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
[TBL] [Abstract][Full Text] [Related]
14. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
[No Abstract] [Full Text] [Related]
15. Mode of action of 15-deoxyspergualin in xenografting islets of Langerhans.
Nakajima Y; Yoshimura A; Kanehiro H; Aomatsu Y; Nakano H
Transplant Proc; 1994 Jun; 26(3):1093-4. PubMed ID: 8029842
[No Abstract] [Full Text] [Related]
16. Synergistic interaction of 15-deoxyspergualin and cyclosporine to prolong the survival of rat islet allografts.
Gores PF; Field JF; Sutherland DE; Chou TC
Transplant Proc; 1994 Apr; 26(2):745. PubMed ID: 8171638
[No Abstract] [Full Text] [Related]
17. 15-Deoxyspergualin protects the islet graft from macrophage-mediated injury.
Juang JH; Hsu BR; Kuo CH
Transplant Proc; 2002 Aug; 34(5):1458-9. PubMed ID: 12176438
[No Abstract] [Full Text] [Related]
18. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
[No Abstract] [Full Text] [Related]
19. Brequinar in combination with cyclosporine a inhibits islet xenograft rejection for up to 24 days: a study in the pig-to-rat model.
Wennberg L; Song Z; Wijkström M; Zhang J; Bari S; Sundberg B; Groth CG; Korsgren O
Transplant Proc; 2000 Aug; 32(5):1026. PubMed ID: 10936333
[No Abstract] [Full Text] [Related]
20. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
